Pharmacological Interventions for Osteoporosis

Evaluate the efficacy and safety of pharmacological agents used in the prevention and treatment of osteoporosis, including bisphosphonates, selective estrogen receptor modulators (SERMs), and monoclonal antibodies targeting RANKL.

    Related Conference of Pharmacological Interventions for Osteoporosis

    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    June 25-26, 2026

    6th European Endocrinology and Diabetes Congress

    London, UK
    June 25-26, 2026

    5th International Summit on Hormonal Disorders

    London, UK
    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    July 23-24, 2026

    28th World Congress on Diabetes and Endocrine Disorders

    Paris, France
    August 17-18, 2026

    6th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    August 20-21, 2026

    6th Annual Summit on Diabetes and Endocrinology

    Paris, France
    September 23-24, 2026

    24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France
    September 28-29, 2026

    25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Berlin, Germany
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    November 23-24, 2026

    35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Amsterdam, Netherlands
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands